Skip to content
The Biotech Codex

The Biotech Codex

Decoding the Science of Life

  • Genetics
  • Biotechnology
  • Healthcare
  • AI
  • Lifestyle
  • Pharma
  • Biohacking
  • Nutrition
  • Testing
  • Opinion

Author: Martin Kardzhilov

Martin Kardzhilov is co-founder and CEO of BrainLayer, where he leads the commercialization of NeuroAI into enterprise Physical AI. He has founded and exited multiple ventures and raised over $100M, including backing from a16z.
NeuroAI Needs a Definition Before It Needs a Budget
Neuroscience

NeuroAI Needs a Definition Before It Needs a Budget

Martin KardzhilovOctober 15, 2026October 15, 2026

NeuroAI is used to describe everything from brain-inspired chip design to neural decoding. Until the field agrees on what it…

The Humanoid Industry Has a Capacity Problem It Cannot Announce Away
Robotics

The Humanoid Industry Has a Capacity Problem It Cannot Announce Away

Martin KardzhilovOctober 15, 2026October 15, 2026

Announced production capacity now runs an order of magnitude ahead of units doing paid work. The constraint is not manufacturing…

The Biotech Codex
  • About Us
  • Contact
  • Editorial Policy
  • Submissions

Copyright © 2026 The Biotech Codex